Unknown

Dataset Information

0

Efficacy of postprocedural anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A post-hoc analysis of the randomized INNOVATION trial.


ABSTRACT: There exists controversy on whether and for how long anticoagulation is necessary after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI).We aimed to study the impact of prolonged (>24?h) or brief (<24?h) postprocedural anticoagulation on infarct size assessed by cardiac magnetic resonance (CMR) after 30 days as well as on left ventricular ejection fraction (LVEF) and left ventricular (LV) remodeling evaluated by 2D-echocardiography after 9 months from the INNOVATION trial (Clinical Trial Registration: NCT02324348).Of the 114 patients (mean age: 59.5 years) enrolled, 76 (66.7%) received prolonged anticoagulation therapy (median duration: 72.6?h) and 38 (33.3%) patients received brief anticoagulation therapy (median duration: 5?h) after primary PCI. There was no significant difference in infarct size (mean size: 15.6% after prolonged anticoagulation versus 19.8% after brief anticoagulation, P = .100) and the incidence of microvascular obstruction (50.7% versus 52.9%, P?=?.830) between the groups. Even after adjusting, prolonged anticoagulation therapy could not reduce larger infarct (defined as >75 percentile of infarct size; 19.7% versus 35.3%; adjusted odd ratio [OR]: 0.435; 95% confidence interval [CI]: 0.120-1.57; P?=?.204). Similar results were observed in subanalyses of major high-risk subgroups. Moreover, follow-up LVEF <35% (3.2% versus 7.4%; adjusted OR: 0.383; 95% CI: 0.051-2.884; P?=?.352) and LV remodeling (defined as >20% increase in LV end-diastolic volume; 37.1% versus 18.5%; adjusted OR: 2.249; 95% CI: 0.593-8.535; P?=?.234) were similar between groups.These data suggest that prolonged postprocedural anticoagulation may not provide much benefit after successful primary PCI in patients with STEMI. However, further studies are needed.

SUBMITTER: Song PS 

PROVIDER: S-EPMC6831338 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Efficacy of postprocedural anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A post-hoc analysis of the randomized INNOVATION trial.

Song Pil Sang PS   Kim Min Jeong MJ   Jeon Ki-Hyun KH   Lim Sungmin S   Park Jin-Sik JS   Choi Rak Kyeong RK   Kim Je Sang JS   Lee Hyun Jong HJ   Kim Tae-Hoon TH   Choi Young Jin YJ   Lim Do-Sun DS   Yu Cheol Woong CW  

Medicine 20190401 17


There exists controversy on whether and for how long anticoagulation is necessary after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI).We aimed to study the impact of prolonged (>24 h) or brief (<24 h) postprocedural anticoagulation on infarct size assessed by cardiac magnetic resonance (CMR) after 30 days as well as on left ventricular ejection fraction (LVEF) and left ventricular (LV) remodeling evaluated by 2D-echocardiography after 9 m  ...[more]

Similar Datasets

| S-EPMC4124048 | biostudies-literature
| S-EPMC5880555 | biostudies-other
| S-EPMC4990737 | biostudies-other
| S-EPMC5898983 | biostudies-literature
| S-EPMC8120407 | biostudies-literature
| S-EPMC8454141 | biostudies-literature
| S-EPMC5814984 | biostudies-literature
| S-EPMC6692400 | biostudies-literature
| S-EPMC8649522 | biostudies-literature
| S-EPMC8476228 | biostudies-literature